Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, NSW, 2065, Australia.
NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Pacific Highway, St Leonards, NSW, 2065, Australia.
Endocr Pathol. 2019 Jun;30(2):113-117. doi: 10.1007/s12022-019-9567-6.
C cell hyperplasia is considered a precursor lesion for hereditary forms of medullary thyroid carcinoma. It has therefore been suggested as a morphological marker to distinguish hereditary from sporadic medullary thyroid carcinoma and to triage genetic testing in resource poor settings. However, numerous definitions for C cell hyperplasia have been suggested, and there is surprisingly little data regarding the number of C cells present in thyroid glands removed for conditions other than medullary carcinoma. We therefore sought to investigate the specificity of different criteria for C cell hyperplasia. We examined the number of C cells and solid cell nests (ultimobranchial body remnants) present in 118 completion thyroidectomy specimens from patients without medullary carcinoma and with no risk factors for MEN2. Morphological review was performed on all H&E-stained slides, and immunohistochemistry for calcitonin was performed on one block from each case. Solid cell nests were found in 4 (3.3%) of thyroids. Increased numbers of C cells sufficient to fulfil criteria for C cell hyperplasia were found in 5 (4.2%) to 36 (30.5%) cases depending on the criteria used. We conclude that large numbers of C cells are commonly found in thyroids not associated with medullary carcinoma. Therefore, regardless of which criteria are used, the presence of C cell hyperplasia is not a specific marker for hereditary medullary thyroid carcinoma.
C 细胞增生被认为是遗传性甲状腺髓样癌的前体病变。因此,它被建议作为一种形态学标志物,以区分遗传性和散发性甲状腺髓样癌,并在资源匮乏的环境中进行基因检测。然而,已经提出了许多关于 C 细胞增生的定义,并且关于除甲状腺髓样癌以外的情况下甲状腺中存在的 C 细胞数量的数据却很少。因此,我们试图研究不同 C 细胞增生标准的特异性。我们检查了 118 例来自无甲状腺髓样癌且无 MEN2 危险因素的患者的甲状腺切除术标本中的 C 细胞和实性细胞巢(终末细支气管体残迹)的数量。对所有 H&E 染色切片进行形态学检查,并对每个病例的一个块进行降钙素免疫组化检查。在 4 个(3.3%)甲状腺中发现了实性细胞巢。根据使用的标准,发现 5 个(4.2%)至 36 个(30.5%)的病例中 C 细胞数量增加,足以满足 C 细胞增生的标准。我们的结论是,大量的 C 细胞通常存在于与甲状腺髓样癌无关的甲状腺中。因此,无论使用哪种标准,C 细胞增生的存在都不是遗传性甲状腺髓样癌的特异性标志物。